MGP Ingredients (MGPI) Trailing US$106.5 Million Loss Tests Bullish Margin Recovery Narratives
MGP Ingredients, Inc. MGPI | 0.00 |
MGP Ingredients (MGPI) has just put Q1 2026 under the microscope, with recent quarters showing revenue moving from US$161.5 million in Q3 2024 to US$130.9 million in Q3 2025, and basic EPS shifting from US$1.07 to US$0.71 over the same period. Q4 2025 came in at US$138.3 million of revenue and a basic EPS loss of US$6.22. Over the trailing twelve months to Q4 2025, revenue was US$536.4 million and basic EPS was a loss of US$4.99. This sets up Q1 2026 as a check on whether margins are stabilising or still under pressure.
See our full analysis for MGP Ingredients.With the headline numbers on the table, the next step is to line them up against the prevailing stories about MGP Ingredients to see which narratives hold up and which ones start to look out of date.
Trailing losses now above US$100 million
- Over the last twelve months to Q4 2025, MGP Ingredients booked a net loss of US$106.5 million on US$536.4 million of revenue, compared with quarterly losses ranging from roughly US$3 million to US$133 million in the individual periods provided.
- Bears argue that widening losses, cited at 23% a year over five years, signal pressure on the business even as some segments benefit from premium spirits and health focused ingredients. This tension shows up in the data where a large Q4 2025 loss of US$133.0 million sits alongside earlier 2025 quarters that were modestly profitable.
- Critics highlight that two quarters in 2025 showed net income of US$14.3 million and US$15.2 million, yet the full year still swung to a trailing EPS loss of US$4.99, which fits the bearish concern that profitability has been fragile.
- The bearish narrative also points to a 50% drop in Distilling Solutions sales and gross profit pressure, and the sequence from a profit in Q3 2025 to a much larger loss in Q4 is consistent with that concern about segment volatility feeding into the overall result.
Revenue near US$536 million while forecasts see slight drift lower
- Reported revenue over the last twelve months to Q4 2025 was US$536.4 million, and the provided forecasts describe revenue drifting about 0.7% a year lower over the next three years rather than growing from this base.
- Consensus narrative leans on premium and craft spirits, plus ingredient exports, to support margins even if revenue stays flat. This lines up with the guidance that analysts expect revenue around the current US$536 million level while looking for profit margins to move from a loss position today to around 10% in three years.
- Supporters of this view point to analysts expecting earnings of US$53.7 million and EPS of US$2.52 by about 2029 on roughly US$540 million of revenue, which assumes the company can keep sales steady and improve mix and costs.
- At the same time, the history of revenue stepping from US$737.7 million on a trailing basis at Q3 2024 to US$536.4 million by Q4 2025 gives investors a clear data point to test whether this flatter future revenue path is realistic.
Share price at US$19.19 against DCF value of about US$38.01
- The shares trade at US$19.19 while the provided DCF fair value is US$38.01 and the consensus analyst target is US$28.80, and the stock’s P/S of 0.8x sits below both peers at 1.9x and the wider US Beverage industry at 1.4x.
- The bullish narrative leans heavily on forecasts that earnings could grow around 99% a year and turn positive within three years, and the current discount to both DCF fair value and the consensus target is part of why bulls see room for a rerating even though trailing EPS over the last year is a loss of US$4.99.
- Supporters of the bullish case point to expected EPS of US$3.03 on earnings of US$65.6 million by around 2029, which would be a large swing from the current trailing loss and could make today’s 0.8x P/S look low if achieved.
- On the other hand, the same data reminds readers that the company has been unprofitable on a trailing basis and that the current 2.5% dividend has not been covered by earnings, so any rerating would likely depend on those forecast margin gains starting to appear in future reports.
Next Steps
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for MGP Ingredients on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
With mixed signals on losses, revenue, and valuation, it helps to see the full picture for yourself and decide where you stand. To weigh up both sides of the story, take a closer look at the 2 key rewards and 1 important warning sign.
Explore Alternatives
MGP Ingredients currently faces a trailing loss of US$106.5 million, weak EPS, and an uncovered 2.5% dividend, which raises questions about income reliability.
If you want income that looks better supported by underlying earnings, it is worth scanning our 12 dividend fortresses today and comparing those options against MGPI.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
